This page has been robot translated, sorry for typos if any. Original content here.

Attention! Information is for reference only!
Before taking, be sure to consult a doctor!
SITE ONLY DIRECTORY. NOT A PHARMACY! We do not sell medicines! None!

Medication Description: Proper-myl

PROPER-MIL (Proper-myl) *.

A complex of lyophilized Saccharomycete fungi (Cryptococcus albicans, Сandida tropicalis, Saccharomyces cerevisiae).

Used to treat patients with multiple sclerosis.

The drug is administered intravenously. Before the introduction dilute the contents of the vial in 5 ml of solvent. The suspended slurry is in the form of a slightly opalescent suspension. Before injection, the suspension is slightly shaken.

Begin injection with the introduction of 0.1 ml of suspension. Daily dose increased by 0.1 ml; with good tolerance from the 8th-10th day of treatment, the daily dose can be increased by 0.2 ml, gradually bringing it to 2, 5-3.0 ml (not more). At a dose of 2, 5, 3, 0 ml of the drug is administered until the end of the course, lasting 30 to 40 days. The same course of treatment can be repeated after 3 - 4 months.

At the first injections, due to the small volume of injected drug (0.1-0.2 ml, etc.), this amount should be collected from the vial with a small (insulin) syringe and, following the rules of asepsis, add to 2 - 3 ml 5% glucose solution; enter the resulting suspension into a vein. From the remaining diluted drug in the vial, you can enter an additional 0.5 1, 0 ml intramuscularly. The unused portion of the drug is poured; open vial cannot be stored.

Injections must be combined with medical gymnastics, massage, etc.

Between courses it is recommended to treat with prednisolone, corticotropin, cocarboxylase, ATP, prozerin (or galantamine), vitamins (B 1, B 6, B 12, nicotinic acid). Cottage cheese, fish, oatmeal, beans, fresh vegetables and fruits should be added to the diet.

Product: in bottles containing 10 million yeast cells. A vial with a solvent (5 ml of 5% glucose solution) is attached to the vial.